Agenus Inc. (NASDAQ:AGEN) is on recovery track with 97.4% gain from a 1-year low price of $1.54. The company added 1% to attain the price of $3.04 on 6/25/2019. Throughout the recent session, the prices were hovering between $3 and $3.1. These shares are 80.92% off its target price of $5.5 and the current market capitalization stands at $405.44M. The recent change has given its price a 10.42% lead over SMA 50 and -21.65% deficit over its 52-week high. The stock witnessed 6.29% gains, 2.7% gains and 34.51% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found AGEN’s volatility during a week at 2.44% and during a month it has been found around 4.31%.

Agenus Inc. (AGEN) Top Holders

Institutional investors currently hold around $134 million or 33.4% in AGEN stock. Look at its top three institutional owners: Rtw Investments, Lp owns $29.75 million in Agenus Inc., which represents roughly 7.34% of the company’s market cap and approximately 22.2% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 8,375,522 shares of the stock are valued at $25.21 million. The third largest holder is Vanguard Group Inc, which currently holds $14.29 million worth of this stock and that ownership represents nearly 3.52% of its market capitalization.

Agenus Inc. 13F Filings

At the end of March reporting period, 52 institutional holders increased their position in Agenus Inc. (NASDAQ:AGEN) by some 7,917,479 shares, 33 decreased positions by 1,610,817 and 28 held positions by 34,882,475. That puts total institutional holdings at 44,410,771 shares, according to SEC filings. The stock grabbed 18 new institutional investments totaling 781,135 shares while 12 institutional investors sold out their entire positions totaling 250,493 shares.

Agenus Inc. (NASDAQ:AGEN) Insider Trades

Multiple company employees have indulged in significant insider trading. Agenus Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Commercial Officer Baysal Ozer has sold 3,712 shares of Agenus Inc. (AGEN) in the trading session dated Dec. 12, 2017. These shares are worth $12,844 and were traded at $3.46 each. The SEC filing shows that Buell Jennifer performed a sale of 3,511 shares. The Chief Communications Officer disposed these shares by way of transaction on Dec. 12, 2017. The company’s shares were given away at $3.46 per share worth to an income of some $12,148 to the account of Buell Jennifer.

Chief Technology Officer, Duncan Alex, sold 6,546 common shares of Agenus Inc. (AGEN) in the open market. In a transaction dated Dec. 12, 2017, the shares were put up for sale at an average price of $3.46, raking in a sum of $22,649. After this sale, 21,026 common shares of AGEN are directly owned by the insider, with total stake valued at $63,919.

In the transaction dated Dec. 12, 2017, a great number of shares sold came courtesy the VP, Finance; KLASKIN CHRISTINE M disposed a total of 5,610 shares at an average price of $3.46, amounting to approximately $19,411. The insider now directly owns 64,333 shares worth $195,572.

Agenus Inc. (AGEN) Analyst Guide

Several analysts have released their opinion on Agenus Inc. (NASDAQ:AGEN), with 2 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.33 average brokerage recommendation [T1].